Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia

Luma Al-Ali; Raad J. Al-Ani; Maysaa M. Saleh; Alaa M. Hammad; Duaa A. Abuarqoub; Bashaer Abu-Irmaileh; Abdallah Y. Naser; Manal M. Najdawi; Manal M. Abbas; Jamal Alyoussef Alkrad

doi:10.1016/j.jsps.2023.101931

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Luma, A., Raad, J. A., Maysaa, M. S., Alaa, M. H., Duaa, A. A., Bashaer, A., Abdallah, Y. N., Manal, M. N., Manal, M. A., Jamal, A. A. (2024). Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2023.101931